NCT Number: NCT02379533
Effects of Home-based or Center-based Aerobic Exercise in Patients With Chronic Kidney Disease
Patients will be randomly assigned to perform the training program in center or home-based . The training program will be conducted in accordance with the recommendations of the American College of Sports Medicine. All training sessions will be preceded by stretching of large muscle groups and heating (5 minutes) and at the end by cool down and stretching (5 minutes). The program will consist of 24 weeks with three sessions per week on alternate days. The aerobic training will be continuous, with an increment of 10 minutes in duration every 4 weeks. The intensity will be prescribed according to ventilatory threshold, characterized by the highest intensity of physical exertion fully maintained by aerobic energy pathways. The intensity control was done by means of the heart rate value obtained at ventilatory threshold.
Both groups receive the same intervention. However, a group exercise held in the center on a treadmill with the direct supervision of a physical education teacher. The other group will exercise at home with telephone follow-up weekly and once a month will be held at the training center under the supervision of a physical education teacher.
It will also constituted a control group remain without performing any activity during the study period. After 24 weeks patients receive the same advice the team conducting the training at home.
Looking for future studies?
Notify MeKey information
Conditions
Age range
30 year–65 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Sedentary individuals with chronic kidney disease stages 3 or 4 disease;
- Both genders;
- Age between 30 and 65 years;
- Overweight (BMI> 25 kg/m2);
- With a negative stress test.
Exclusion criteria
- Patients with chronic obstructive pulmonary disease,
- class IV heart failure,
- myocardial infarction within the last 6 months,
- decompensated hypertension (systolic blood pressure> 180 mmHg or diastolic> 110 mmHg in the last 6 months),
- uncontrolled cardiac arrhythmia,
- decompensated diabetes mellitus (glycated hemoglobin> 8.0%),
- unstable angina,
- infectious processes in the last 3 weeks;
- begin use of erythropoietin or with hemoglobin <11g/L.
- use of beta-blocker medication
Treatment and study plan
Primary outcomes
-
Cardiopulmonary capacity
Time frame: 24 weeks
The test began with a fixed inclination of 1%. The initial velocity was 2 km/h during the first three minutes with increments of 0.5km/h every minute until the patient reaches physical exhaustion. The ventilatory variables were measured using a gas analyzer. The highest oxygen uptake obtained during the last stage reached was considered the peak oxygen uptake. The ventilatory threshold was determined as the stage preceding the first occurrence of the exponential increase in ventilation, increase in the ventilatory equivalent for oxygen and increase in expired fraction of oxygen. The respiratory compensation point was determined as the stage preceding the second occurrence of the exponential increase in ventilation, increase in the ventilatory equivalent for carbon dioxide and decrease in end-tidal carbon dioxide. Data were analyzed by the average of 20 seconds.
-
Functional capacity (walk, sit-stand, arm curl, sit-reach, back scratch, timed up and go)
Time frame: 24 weeks
Functional capacity was assessed using a variety of objective measures. These included six-minute walk test (maximal distance walked along an internal corridor during six minutes), two-minute step test (maximal number of steps achieved in stationary walking during two minutes, used to quantifying the aerobic power), sit-to-stand test (maximal sit to stand cycles achieved in 30 seconds, used to quantifying the muscular endurance of the legs), arm curl test (maximal number of arm curl cycles in 30 seconds, used to quantifying the muscular endurance of the arms), sit and reach test (maximal distance achieved in the Wells bench, used to quantifying the general flexibility), back scratch test (maximum amplitude of the arms used to quantifying the arms flexibility) and time up and go test (shorter time to rise from a chair, walk three meters and sit back, used to quantifying the functional mobility).
Secondary outcomes
-
Quality of life
Time frame: 24 weeks
The Short-Form Health Survey (SF-36) questionnaire was applied to assess the quality of life. The scores for each domain range from 0 to 100%. The higher scores define a better quality of life. The questionnaire was applied individually in a clear and quiet room with the patient rested.
-
sleep quality (PSQI)
Time frame: 24 weeks
The PSQI assesses the quality of sleep for the last month of the interview. The questionnaire has 19 questions that comprise seven assessment components: quality of sleep, latency, duration, efficiency, nocturnal sleep disturbances, use of sleep medication and daytime sleepiness. Each component receives a score from 0 to 3, in a way that the final score can range between 0 and 21. The higher the score, the worse the quality of sleep, and scores higher than five indicate sleep disturbances.
-
blood pressure
Time frame: 24 weeks
Blood pressure and resting heart rate were measured before the cardiopulmonary exercise test.
Sponsors and collaborators
Lead sponsor
Federal University of São Paulo
Other
Collaborators
- Fundação de Amparo à Pesquisa do Estado de São Paulo
Registry information
Official study title
Effects of Home-based or Center-based Aerobic Exercise on Physical Function, Nutritional Status Ans Cardiopulmonary Parameters in Patients With Chronic Kidney Disease
Acronym: HBCKD
Important dates
- Study start
- 2009
- Primary completion
- 2013
- Study completion
- 2013
- First posted
- Mar 5, 2015
- Registry last updated
- Mar 26, 2015
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
A Study to Investigate the Mechanistic Effects of Dapagliflozin Alone or in Combination With Balcinrenone, Compared to Balcinrenone and Placebo on Body Fluid and Electrolyte Handling and Energy Metabolism in Participants Over 50 Years of Age With Chronic Kidney Disease.
NCT05884866
Chronic Disease, Chronic Kidney Disease Stage 3
Marseille, France
View Trial DetailsObservational Study of the Use of Extraneal in Peritoneal Dialysis in Patients
NCT06492031
Chronic Disease, Chronic Renal Failure
Beijing, China
View Trial DetailsPremarket Clinical Safety Assessment of the ELISIO™-HX
NCT07058909
Acute Kidney Injury, Acute Renal Failure
Norfolk, Virginia, United States
View Trial DetailsIdentification of Palliative Care Needs and Prognostic Factors of Survival in Tailoring Appropriate Interventions in Advanced Oncological, Renal and Pulmonary Diseases
NCT06909968
Cancer, Chronic Disease
Bologna, BO, Italy
View Trial Details